The Global Healthy Living Foundation (GHLF) is a 501 (c)(3) patient advocacy organization
that works to improve the quality of life for people living with chronic …

The U.S. Food and Drug Administration (FDA) approved the first biosimilar in early March. Three others are undergoing the agency’s review, which is just the tip of the iceberg…

My name is Candice Dusset. I’m a patient advocate and member of the Global Healthy Living Foundation’s 50 State Network.

Steve Marmaras on AM Baton Rouge discussing about biosimilar legislation.

We can all likely agree we’re lucky drugs aren’t recalled as frequently as cars.

Victory number FIVE! Our Patient Advocate Regan submitted her testimony to North Carolina state government putting patient safety and transparency at the forefront of decision making.

Washington is the fourth state this year to pass a bill that notifies physicians when there patients’ medication has been substituted.

Attached please find a comment letter concerning House Bill 319 which addresses the substitution of biologics and interchangeable biosimilars. We kindly request that you support this bill. We believe that HB 319 …

Unlike traditional chemical drugs, biologics have unique, complex structures made from living cells that are not easily understood or replicated. A small change or difference in the biosimilar or biologic has the potential to either help or adversely affect patients like me.

I am writing to you today on behalf of the more than 80,000 members nationwide of
CreakyJoints.org, a part of the Global Healthy Living Foundation, to express our support